Mandavia R, Lapa T, Smith M, Bhutta M F
UCL Ear Institute, London, UK.
Royal National Nose Throat and Ear Hospital, London, UK.
Clin Otolaryngol. 2018 Feb;43(1):31-38. doi: 10.1111/coa.12898. Epub 2017 May 28.
Hearing loss is a neglected international health problem. The greatest burden of ear disease is in low-income countries where there is also a lack of resources. In this context, screening for otological disease may be worthwhile. Cupris© has developed an otoscopy device that offers the possibility of low-cost mass screening in remote communities. We evaluated the validity of this device in diagnosing ear disease and in determining whether referral to an ENT centre is warranted.
Cross-sectional study.
Outpatient clinic, Nepal.
All adults and children were invited to take part over a 2-day period. The Cupris© device was used to record participants otological history and examination. Stored history and images were assessed in the United Kingdom by a Consultant-grade ENT Surgeon, who provided a diagnosis and decided whether referral to an ENT centre was warranted. After screening with the Cupris© device, participants were immediately assessed by a UK trained ENT Consultant Surgeon using a standard otoscope ("standard assessment"). A diagnosis was recorded for each participant and a decision was made as to whether referral to an ENT centre was warranted.
Concordance in primary diagnosis (analysed per ear) and concordance in the decision to refer (analysed per patient). Cohen's kappa coefficient for inter-rater agreement in diagnosis.
Fifty-six patients agreed to participate. In four patients, the quality of video recorded precluded a diagnosis or management plan. These patients were excluded from subsequent analysis, leaving 52 patients for analysis. The same diagnosis was reached for 99 of 104 ears when comparing the Cupris© device to standard assessment (95% concordance), with Cohen's kappa coefficient of 0.89. The decision as to whether a patient should be referred to an ENT centre for further assessment was the same for all 52 participants when comparing the Cupris© device to standard assessment.
When compared to standard assessment, the Cupris© device is a valid tool for the diagnosis of ear disease and decision for onward referral. It shows considerable promise for use by trained non-medical workers, as a low-cost and portable tool to screen for ear disease in remote settings, particularly in low- and middle-income countries.
听力损失是一个被忽视的国际健康问题。耳部疾病的最大负担存在于资源匮乏的低收入国家。在这种情况下,耳部疾病筛查可能是有价值的。Cupris©公司开发了一种耳镜设备,该设备提供了在偏远社区进行低成本大规模筛查的可能性。我们评估了该设备在诊断耳部疾病以及确定是否有必要转诊至耳鼻喉科中心方面的有效性。
横断面研究。
尼泊尔的门诊诊所。
在为期两天的时间里,邀请了所有成人和儿童参与。使用Cupris©设备记录参与者的耳部病史和检查情况。存储的病史和图像在英国由一位顾问级耳鼻喉科外科医生进行评估,该医生给出诊断并决定是否有必要转诊至耳鼻喉科中心。在用Cupris©设备进行筛查后,参与者立即由一位在英国接受培训的耳鼻喉科顾问外科医生使用标准耳镜进行评估(“标准评估”)。记录每位参与者的诊断结果,并决定是否有必要转诊至耳鼻喉科中心。
主要诊断的一致性(按每只耳朵分析)以及转诊决定的一致性(按每位患者分析)。诊断中评估者间一致性的Cohen's kappa系数。
56名患者同意参与。4名患者的视频记录质量妨碍了诊断或制定管理计划。这些患者被排除在后续分析之外,剩余52名患者进行分析。将Cupris©设备与标准评估相比较时,104只耳朵中有99只得出了相同的诊断结果(一致性为95%),Cohen's kappa系数为0.89。将Cupris©设备与标准评估相比较时,所有52名参与者关于是否应转诊至耳鼻喉科中心进行进一步评估的决定是相同的。
与标准评估相比,Cupris©设备是诊断耳部疾病和决定后续转诊的有效工具。作为一种低成本且便于携带的工具,它对于经过培训的非医务人员在偏远地区,特别是在低收入和中等收入国家筛查耳部疾病显示出了巨大的前景。